Nephrology Division, Massachusetts General Hospital, Boston, Massachusetts, United States.
Department of Medicine, Harvard Medical School, Boston, Massachusetts, United States.
Am J Physiol Renal Physiol. 2023 Dec 1;325(6):F695-F706. doi: 10.1152/ajprenal.00166.2023. Epub 2023 Sep 28.
Kidney organoids are three-dimensional structures generated from pluripotent stem cells (PSCs) that are capable of recapitulating the major structures of mammalian kidneys. As this technology is expected to be a promising tool for studying renal biology, drug discovery, and regenerative medicine, the functional capacity of kidney organoids has emerged as a critical question in the field. Kidney organoids produced using several protocols harbor key structures of native kidneys. Here, we review the current state, recent advances, and future challenges in the functional characterization of kidney organoids, strategies to accelerate and enhance kidney organoid functions, and access to PSC resources to advance organoid research. The strategies to construct physiologically relevant kidney organoids include the use of organ-on-a-chip technologies that integrate fluid circulation and improve organoid maturation. These approaches result in increased expression of the major tubular transporters and elements of mechanosensory signaling pathways suggestive of improved functionality. Nevertheless, continuous efforts remain crucial to create kidney tissue that more faithfully replicates physiological conditions for future applications in kidney regeneration medicine and their ethical use in patient care. Kidney organoids are three-dimensional structures derived from stem cells, mimicking the major components of mammalian kidneys. Although they show great promise, their functional capacity has become a critical question. This review explores the advancements and challenges in evaluating and enhancing kidney organoid function, including the use of organ-on-chip technologies, multiomics data, and in vivo transplantation. Integrating these approaches to further enhance their physiological relevance will continue to advance disease modeling and regenerative medicine applications.
肾类器官是由多能干细胞(PSCs)生成的三维结构,能够重现哺乳动物肾脏的主要结构。由于这项技术有望成为研究肾脏生物学、药物发现和再生医学的有前途的工具,因此肾类器官的功能能力成为该领域的一个关键问题。使用几种方案产生的肾类器官具有天然肾脏的关键结构。在这里,我们回顾了肾类器官功能特征化的当前状态、最新进展和未来挑战、加速和增强肾类器官功能的策略,以及获得 PSC 资源以推进类器官研究。构建生理相关肾类器官的策略包括使用器官芯片技术,该技术整合了流体循环并促进类器官成熟。这些方法导致主要管状转运蛋白的表达增加,机械感觉信号通路的元素也增加,表明功能得到改善。然而,为了创造更真实地模拟生理条件的肾脏组织,以便在未来的肾脏再生医学应用中使用,并在患者护理中合理使用,仍需要持续努力。肾类器官是源自干细胞的三维结构,模拟哺乳动物肾脏的主要成分。尽管它们具有很大的应用潜力,但它们的功能能力已成为一个关键问题。本文综述了评估和增强肾类器官功能的最新进展和挑战,包括器官芯片技术、多组学数据和体内移植的应用。整合这些方法将继续推进疾病建模和再生医学应用,以进一步提高它们的生理相关性。